Beijing Wisdomab Biotechnology Co., Ltd

Genrix (shanghai) Biopharmaceutical Co. Ltd.

Chongqing Genrix Biopharmaceutical Co., Ltd.

Beijing Bettermab Biotechnology Co., Ltd

Chongqing Genrix Biopharmaceutial Co., Ltd.

Yulan Liu

Zhigang Liu

Jingjing Guo

Xiaobo Hao

Lei Jiang

Shijie Shen

Disclosed in the present application are an antibody or an antigen-binding portion thereof binding to human IL-4R, a polynucleotide encoding the antibody or antigen-binding portion thereof, a vector comprising the polynucleotide, a host cell comprising the polynucleotide or vector, a method for preparing and purifying the antibody, and the use of the antibody or antigen-binding portion thereof.

Anti-IL-4R antibody and use thereof

The present application provides a bispecific antibody against rabies virus, and an application thereof. The bispecific antibody comprises two antigen-binding fragments binding to different epitopes of G protein of rabies virus, and has rabies virus neutralization activity.

Bispecific antibody against rabies virus, and application thereof

The present application discloses a novel anti-human IL-17 monoclonal antibody obtained by phage antibody library screening and genetic engineering, or a functional fragment thereof, a polynucleotide encoding the monoclonal antibody or the functional fragment thereof, a vector comprising the polynucleotide, a host cell comprising the polynucleotide or vector, a method for preparing and purifying the antibody, and use of the antibody or the functional fragment thereof.

Anti-human IL-17 monoclonal antibodies and use thereof

Growing community of inventors

Beijing, China

Yulan Liu